↓ Skip to main content

Dove Medical Press

Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date

Overview of attention for article published in HIV/AIDS (Auckland, N.Z.), October 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (61st percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
1 X user
patent
5 patents

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
48 Mendeley
Title
Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date
Published in
HIV/AIDS (Auckland, N.Z.), October 2018
DOI 10.2147/hiv.s145529
Pubmed ID
Authors

Lucas Hill, Shawn R Smith, Maile Young Karris

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 10%
Student > Master 5 10%
Other 4 8%
Student > Doctoral Student 4 8%
Researcher 4 8%
Other 11 23%
Unknown 15 31%
Readers by discipline Count As %
Medicine and Dentistry 12 25%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Nursing and Health Professions 4 8%
Immunology and Microbiology 4 8%
Agricultural and Biological Sciences 2 4%
Other 3 6%
Unknown 19 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2024.
All research outputs
#7,963,683
of 25,385,509 outputs
Outputs from HIV/AIDS (Auckland, N.Z.)
#75
of 330 outputs
Outputs of similar age
#132,074
of 354,551 outputs
Outputs of similar age from HIV/AIDS (Auckland, N.Z.)
#2
of 9 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 330 research outputs from this source. They receive a mean Attention Score of 3.5. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 354,551 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.